Recently, the roles of toll like receptor (TLR) gene polymorphisms in atherosclerotic diseases were extensively investigated, with conflicting results. Therefore, we performed this study to better assess the relationship between TLR gene variants and atherosclerosis. Eligible studies were searched in PubMed, MEDLINE, EMBASE, Web of Science and CNKI. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to estimate associations between TLR gene polymorphisms and atherosclerosis. A total of 40 studies covering 19,657 cases and 15,660 controls were finally included in our systematic review and metaanalysis. Significant correlations with atherosclerosis susceptibility were found for the TLR1 rs5743551 polymorphism (dominant model: 95% CI 1.03-1.79; recessive model: 95% CI 0.28-0.97; allele model: 95% CI 1.07-1.69), TLR1 rs5743611 polymorphism (dominant model: 95% CI 0.56-0.98) and TLR6 rs5743810 polymorphism (recessive model: 95% CI 0.56-0.92) in overall analyses. Moreover, further subgroup analyses revealed that TLR4 rs1927911 polymorphism was significantly associated with the risk of cerebral infarction in the recessive model (95% CI 0.46-0.96), whereas TLR4 rs4986791 polymorphism was significantly correlated with susceptibility to atherosclerosis among Asians in the dominant (95% CI 1.58-6.66), additive (95% CI 0.13-0.69) and allele (95% CI 1.58-5.53) models. However, no positive results were found for the other 13 TLR polymorphisms. In conclusion, our findings indicate that most TLR gene polymorphisms may not be implicated in the pathogenesis of atherosclerosis, whereas certain TLR gene variations, such as rs5743551, rs5743611, rs5743810, rs4986791 and rs1927911, may serve as genetic biomarkers of atherosclerotic diseases.
Introduction
Atherosclerosis is characterized by dysfunction of endothelium, accumulation of lipids, infiltration of macrophages and lymphocytes, proliferation of vascular smooth muscles cells, hyperplasia of connective tissue and formation of atherosclerotic plagues in arteries of all sizes [1] . It results in thickening and elasticity loss of arterial wall, and it is the major cause of multiple severe arterial occlusive diseases such as coronary artery disease, ischaemic stroke, carotid artery stenosis, renal artery obstruction, retinal artery occlusion and peripheral arterial disease [2, 3] .
To date, the exact underlying pathogenic mechanism of atherosclerosis is still not fully elucidated. Nevertheless, there is abundant evidence to support that genetic characteristics play a central role in the pathogenesis of atherosclerosis. Firstly, previous family-based association studies have demonstrated that the heritability of atherosclerosis varying from 40% to 60% [4, 5] . Besides, it has been shown that positive family history is a strong independent risk factor of atherosclerosis-related diseases [6] . Secondly, nearly 60 genetic loci have been found to be correlated with the susceptibility to atherosclerosis by recent genome-wide association studies [7, 8] , and screening of common causal variants in asymptomatic family members has been proved to be a cost-effective way to predict the risk of atherosclerosis [9, 10] . Thirdly, genetically modified technology has been successful in inducing similar phenotypes of human atherosclerosis in mice and rabbits, and these animal models are already widely used in preclinical studies of atherosclerotic diseases [11, 12] . Overall, these findings jointly indicate that genetic predisposition to atherosclerosis is crucial for its occurrence and development.
Toll like receptors (TLRs) are a group of type 1 transmembrane proteins expressed on a variety of immune cells (such as macrophages, dendritic cells, natural killer cells, T cells and B cells) and non-immune cells (such as epithelial cells, vascular endothelial cells and smooth muscle cells) that recognize stimuli from exogenous pathogens or endogenous cell damage [13] . The binding of TLRs with their corresponding ligands leads to recruitment of adaptor proteins, activation of downstream signal transduction pathways, upregulation of cytokine and chemokine production and ultimately the development of immune responses [14] . Previous studies have shown that inflammatory markers closely related to the TLR signalling pathway, such as C-reactive protein, tumour necrosis factor-alpha, intercellular adhesion molecule-1 and interleukin-6, are significantly elevated in atherosclerosis patients [15, 16] . Moreover, accumulating evidence suggests that blockage of the TLR signalling pathway could result in reduction of atherosclerosis [17, 18] , while activation of the TLR signalling pathway could promote atherogenesis in animal models [19, 20] . Consequently, the TLR genes variants are thought to be ideal candidate biomarkers of atherosclerosis susceptibility.
So far, several pilot studies have already tried to investigate the potential roles of TLR gene polymorphisms in atherosclerotic diseases. But the results of these studies were conflicting. Thus, we conducted the present systematic review and meta-analysis to better assess the potential associations between TLR gene polymorphisms and atherosclerosis.
Materials and methods
Literature search and inclusion criteria. The current systematic review and meta-analysis were performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement [21] . Potentially relevant articles were searched in PubMed, MEDLINE, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) using the following key words: 'Toll like receptor', 'TLR', 'polymorphism', 'variant', 'genotype', 'allele', 'atherosclerosis', 'arteriosclerosis', 'coronary heart disease', 'coronary artery disease', 'angina pectoris', 'acute coronary syndrome', 'myocardial infarction', 'ischaemic stroke', 'cerebral infarction', 'brain infarction', 'cerebral ischaemia', 'brain ischaemia', 'transient ischaemic attack', 'carotid artery stenosis', 'carotid stenosis', 'renal artery stenosis', 'renal artery obstruction', 'retinal artery occlusion' and 'peripheral arterial disease'. The initial literature search was conducted in November 2016, and the latest update was finished in February 2017. In addition, the reference lists of all retrieved articles were also screened to identify other potentially related literatures.
Included studies should met all the following criteria: (1) case-control study on associations of TLR gene polymorphisms with susceptibility to atherosclerotic diseases; (2) offer sufficient data to calculate odds ratios (ORs) with 95% confidence intervals (CIs); (3) full text available. For duplicate reports, only the most recent and complete one was included. Abstracts, pedigree studies, case reports, case series, reviews, comments, letters and conference presentations were intentionally excluded.
Data extraction and quality assessment. The following data were extracted from all included studies: (1) name of first author; (2) year of publication; (3) country and ethnicity of study subjects; (4) type of disease; (5) source of controls; and (6) the genotypic distribution of TLR gene polymorphisms in cases and controls. Additionally, the probability value (P value) of Hardy-Weinberg equilibrium (HWE) test was also calculated on the basis of the genotypic frequencies of certain TLR gene polymorphisms in the control group.
The Newcastle-ottawa scale (NOS) was used to assess the quality of eligible studies from three aspects: (1) selection of cases and controls; (2) comparability between cases and controls; and (3) exposure in cases and controls [22] . The NOS has a score range of zero to nine, and studies with a score of more than seven were considered to be of high quality.
Two reviewers (Xie and Shi) conducted the data extraction and quality assessment independently. When necessary, the reviewers wrote to the corresponding authors for extra information or raw data. Any discordance between two reviewers was settled by discussion with the third reviewer (Liu) until reaching a consensus.
Statistical analysis. All statistical analyses in this study were performed using Review Manager Version 5.3 (The Cochrane Collaboration, Software Update, Oxford, United Kingdom) [23] . ORs and 95% CIs were used to estimate potential associations of TLR gene polymorphisms with susceptibility to atherosclerosis in the dominant, recessive, additive and allele models, and a P value of 0.05 or less was considered as statistically significant. Between-study heterogeneity was evaluated on the basis of Q test and I 2 statistic. If P value of Q test was <0.1, or I 2 was >50%, the random-effect model (REM) would be adopted for analyses due to the existence of obvious heterogeneity. Otherwise, the fixed-effect model (FEM) would be employed for analyses. Subgroup analyses by ethnicity of study population and type of disease were subsequently conducted to obtain more specific results. Sensitivity analyses were carried out to test the stability of the results. Funnel plots were applied to assess possible publication bias.
Results

Characteristics of included studies
The literature search identified 597 potentially relevant articles. After exclusion of irrelevant or duplicate articles by reading titles and abstracts, 72 articles were retrieved for further evaluation. Another 32 articles were subsequently excluded after reading full texts, and a total of 40 studies containing 19,657 cases and 15,660 controls that met the inclusion criteria were finally included in our systematic review and meta-analysis (see Fig. 1 ). All eligible studies were published between 2003 and 2016. Of these, 37 articles were published in English, and the other three articles were published in Chinese. The NOS score of eligible articles ranged from 7 to 9, which indicated that all included studies were of relatively high quality. Characteristics of included studies were summarized in Table 1 .
Overall and subgroup analysis
To investigate the potential associations between TLR gene polymorphisms and atherosclerosis susceptibility, one study about TLR1 gene polymorphisms, nine studies about TLR2 gene polymorphisms, thirty-two studies about TLR4 gene polymorphisms, one study about TLR5 gene polymorphisms, two studies about TLR6 gene polymorphisms, one study about TLR7 gene polymorphisms, one study about TLR8 gene polymorphisms and two studies about TLR9 gene polymorphisms were enrolled for overall analyses. Significant associations with atherosclerosis susceptibility were detected for the TLR1 rs5743551 polymorphism in the dominant (P = 0.03, OR = 1.36, 95% CI 1.03-1. Articles excluded with reasons (n = 32) Reviews/comments/letters (n = 15)
Incomplete data (n = 13) Case series (n = 3) Duplicate reports (n = 1)
Studies included in quantitative synthesis
(meta-analysis) (n = 37) Figure 1 Flowchart of study selection for this study.
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Sensitivity analysis
Sensitivity analyses were performed to examine the stability of meta-analysis results by eliminating studies that deviated from HWE if the original synthetic results were based on at least three studies. No changes of results were detected for investigated TLR gene polymorphisms in any comparisons, which suggested that our findings were statistically reliable.
Publication bias
Potential publication bias in this study was assessed with funnel plots. No obvious asymmetry of funnel plots was observed in any comparisons, which indicated that no severe publication bias existed in our systematic review and meta-analysis.
Discussion
Despite huge advancements in medical therapy and interventional surgery over the past few decades, ischaemic vascular diseases derived from atherosclerosis are still OR, odds ratio; CI, confidence interval; NA, not available; CAD, coronary artery disease; MI, myocardial infarction; IS, ischaemic stroke; CI, cerebral infarction. The values in bold represent there is statistically significant differences between cases and controls.
Ó 2017 The Foundation for the Scandinavian Journal of Immunology leading causes of death and disability globally [24, 25] . So far, the exact cause of atherosclerosis is still largely unknown, and a better understanding of its pathogenic mechanism may be pivotal for further improving the clinical outcomes of atherosclerosis patients. Previous epidemiologic studies have shown that non-genetic factors such as hypercholesterolemia, hypertension, diabetes, obesity and smoking habit may increase the risk of atherosclerosis [26, 27] . Moreover, behaviour changes towards a healthier lifestyle and pharmacologic treatments for these potential pathogenic factors have been proved to be responsible for better prognosis in atherosclerosis patients [28] . However, the obvious familial aggregation tendency of atherosclerosis suggests that certain genetic factors may also contribute to the occurrence and development of this disease.
Recently, the inflammatory nature of atherosclerosis has also been recognized. Firstly, multiple immune cells including macrophages, dendritic cells, T cells and B cells were detected in atherosclerotic plagues [29] . Secondly, pro-inflammatory cytokines such as tumour necrosis factoralpha, interferon-gamma, interleukin-1, interleukin-6 and interleukin-17 were found to promote the development and progression of the disease, while anti-inflammatory cytokines such as transforming growth factor-beta and interleukin-10 could exert anti-atherosclerotic effects [30] . Thirdly, several pilot animal studies also demonstrated that anti-inflammatory and immunesuppressive therapies could result in dramatic reduction of atherosclerosis [31] . Therefore, it is biologically plausible that polymorphisms in immune-related genes may be implicated in the pathogenesis of atherosclerosis.
TLRs are a group of pattern recognition receptors (PRRs) for structural conserved exogenous pathogenassociated molecules (PAMs) and endogenous damageassociated molecules (DAMs), which play prominent roles in evoking immune reactions in response to both infectious and non-infectious stimuli [13] . The interaction of TLRs with their corresponding ligands activates the TLR signalling pathway, which leads to proinflammatory cytokine production and leucocyte infiltration [14] . Given the crucial roles of TLRs in regulating immune responses, the potential correlations of certain TLR gene polymorphisms with susceptibility to inflammatory diseases like atherosclerosis were extensively studied, but the results of these studies were contradictory. Hence, we performed the present systematic review and meta-analysis of all published original studies on relationship between TLR gene polymorphisms and atherosclerotic diseases to better assess the roles of TLR gene variations in atherosclerosis.
Significant correlations with atherosclerosis susceptibility were found for the TLR1 rs5743551 polymorphism (dominant model: P = 0.03, OR = 1.36, 95% CI 1.03-1.79; recessive model: P = 0.04, OR = 0.53, 95% CI 0.28-0.97; allele model: P = 0.01, OR = 1.35, 95% CI 1.07-1.69), TLR1 rs5743611 polymorphism (dominant model: P = 0.03, OR = 0.74, 95% CI 0.56-0.98), and TLR6 rs5743810 polymorphism (recessive model: P = 0.008, OR = 0.72, 95% CI 0.56-0.92) in overall analyses. Moreover, further subgroup analyses revealed that TLR4 rs1927911 polymorphism was significantly associated with the risk of cerebral infarction in the recessive model (P = 0.03, OR = 0.67, 95% CI 0.46-0.96), whereas TLR4 rs4986791 polymorphism was significantly correlated with susceptibility to atherosclerosis among Asians in the dominant (P = 0.001, OR = 3.25, 95% CI 1.58-6.66), additive (P = 0.005, OR = 0.30, 95% CI 0.13-0.69) and allele (P = 0.0007, OR = 2.96, 95% CI 1.58-5.53) models. However, no significant associations with atherosclerosis were detected for the other 13 TLR gene polymorphisms in both overall and subgroup analyses. The stability of the results was subsequently tested in sensitivity analyses, and no statistically significant alterations were observed in any comparisons, which indicated that our synthetic results were quite stable and reliable.
There are several points that need to be addressed. Firstly, it is notable that significant associations obtained in the current study were only based on limited number of studies, and consequently, further replication studies in different subjects are warranted to confirm these findings. Secondly, the pathogenic mechanism of atherosclerosis is extremely complex, and thus, it is unlikely that a single genetic polymorphism can significantly contribute to the occurrence and development of this disease. Therefore, although previous studies supported that TLRs may play important roles in the pathogenesis of atherosclerosis, we did not detect any positive results for most TLR gene polymorphisms, including TLR2 rs3804099, TLR2 rs3804100, TLR2 rs5743708, TLR2 rs121917864, TLR4 rs1927914, TLR4 rs4986790, TLR5 rs5744174, TLR6 rs3775073, TLR7 rs2897827, TLR8 rs3764879, TLR8 rs3764880, TLR9 rs187084 and TLR9 rs5743836. Thirdly, due to lack of raw data, we failed to estimate the relationship between investigated TLR gene polymorphisms. Nevertheless, to better illustrate the potential correlations between TLR gene polymorphisms and atherosclerosis, we strongly suggest further studies to involve haplotype analyses and explore possible gene-gene interactions.
There is no denying that this systematic review and meta-analysis have some limitations. Firstly, our results were based on unadjusted estimations due to lack of original data, and failure to perform further stratified analyses according to age, gender, smoking status and comorbidity conditions may influence the precision of our findings. Secondly, obvious heterogeneity was detected in certain subgroups, indicating that the conflicting results of included studies could not be fully explained by differences in ethnic background of participants or type of disease, and other unmeasured characteristics of study subjects may partially attribute to the between-study heterogeneity. Thirdly, associations between TLR gene polymorphisms and atherosclerosis may also be modified by gene-gene and gene-environmental interactions. However, most studies did not consider these potential interactions, which impeded us to conduct relevant analyses accordingly. Taken these limitations into consideration, the results of the current study should be interpreted with caution.
In conclusion, the present study indicates that most TLR gene variants may not be implicated in the pathogenesis of atherosclerosis, whereas certain TLR gene polymorphisms such as rs5743551, rs5743611, rs5743810, rs4986791 and rs1927911, may serve as genetic biomarkers of atherosclerotic diseases. Further well-designed studies are still warranted to confirm our findings, and future investigations also need to explore the potential roles of other TLR gene variations in atherosclerosis.
